FDA inspection
AstraZeneca Pharmaceuticals, LP: FDA inspection ending Jan 30, 2017
FDA inspection 998797 · Official Action Indicated (OAI) · Coppell, TX
Key facts
| Inspection ID | 998797 |
|---|---|
| Firm | AstraZeneca Pharmaceuticals, LP |
| FEI number | 3010199915 |
| Address | 508 Wrangler Dr Ste 100 |
| City | Coppell |
| State | TX |
| ZIP | 75019 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jan 30, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data